Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma-Reference-Cited by-同舟云学术

Diagnostic accuracy of HNF1β, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma

Published:2022-09 Issue: Volume:237 Page:154019
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Travaglino Antonio,Raffone Antonio,Arciuolo Damiano,Santoro Angela,Inzani Frediano,Di Maio Anna,Visiello Umberto,Fulgione Caterina,Guida Maurizio,Mollo Antonio,Insabato Luigi,Zannoni Gian Franco

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference34 articles.

1. Female Genital Tumours;WHO Classification of Tumours Editorial Board,2020

2. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?;Bae;Int J. Gynecol. Pathol.,2015

3. New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines;Santoro;Cancers,2021

4. Clear cell endometrial carcinoma and the TCGA classification;Travaglino;Histopathology,2020

5. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features;Murali;Diagn. Chall. Recomm. Int. J. Gynecol. Pathol.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in cancer energy metabolism under dietary restriction: a mini review;Medical Oncology;2024-07-26

2. Ovarian endometrioid carcinoma with a sex cord-like pattern: a morphological, immunohistochemical, and molecular analysis;Virchows Archiv;2024-02-29

3. High-Grade Endometrial Carcinoma;Gynecologic and Obstetric Pathology;2024

4. A review of the directly sampled endometrial cytology on LBC samples: Classification, microscopic criteria and beyond;Cytopathology;2023-12-05

5. Mixed squamous and clear cell ovarian adenocarcinoma arising from endometriosis in a 71 year old patient;Gynecologic Oncology Reports;2023-08